News
Abbott 2026 Promotions
Abbott is pleased to announce that Moritz Turck has been promoted to Managing Director.
The U.S. financial markets were largely stable during the first half of Q1 2025, but sentiment turned in mid-February. The major U.S. indices retreated for the quarter, bookended by the S&P 500’s 4.4% decline and the NASDAQ’s fall of 10.4%. Strong performance in defensive sectors such as Energy (9.3%), Healthcare (6.1%) and Consumer Staples (4.6%) were not enough to offset the punishing performance of IT (-12.8%) and Consumer Discretionary (-14.0%) since these two sectors comprise nearly 40% of the S&P500 when weighted by market capitalization. On April 30th, the Bureau of Economic Analysis released its advance estimate for U.S. GDP growth in the first quarter, and reported a decline of 0.3%, versus Q4 2024 growth of 2.4%. Economists attributed much of this contraction to an increase in imports, likely in advance of (at the time) to-be-announced U.S. tariffs. Meanwhile, the U.S. Federal Reserve’s preferred inflation indicator, the Core Personal Consumption Index (excluding food and energy prices), ended the quarter at 2.6%, the lowest reading since Q2 2024, and well below a February spike of 3%.
The European markets fared better, with the FTSE 100 and the Euro STOXX 600, ending the quarter 5% and 5.2% higher than the prior quarter, respectively. Euro Area GDP advanced 0.40% quarter over quarter for Q1 2025, slightly besting the 30-year average of 0.37%. UK GDP expanded slightly, by 0.1%.
As noted below, the quarter brought a surge in venture capital new deal and exit value, both of which were mirrored by North American and European private equity. Secondary dealmaking enjoyed another strong quarter.
That rearview summary, however, seems naïve in mid-May. The on-again, off-again U.S. tariffs have roiled global markets and the uncertainty surrounding tariffs and their eventual impact on the economy hinders business leaders’ ability to make strategic decisions about their business.
While private equity portfolios may be insulated from the daily volatility of the public markets, they are not immune to the challenges that uncertainty, supply chain disruptions and economic slowdowns bring.










SOURCES
Unless otherwise noted, with respect to private equity information, data sourced through: Q1 2024 PitchBook Annual US PE Breakdown, Q1 2025 PitchBook Annual US PE Breakdown, Q1 2024 PitchBook Annual European PE Breakdown, and Q1 2025 PitchBook Annual European PE Breakdown.
Unless otherwise noted, with respect to venture capital information, data sourced through: Q1 2024 PitchBook-NVCA Venture Monitor and Q1 2025 PitchBook-NVCA Venture Monitor.
Unless otherwise noted, with respect to secondaries information, data sourced through: Preqin historical fundraising data for secondaries and direct secondaries funds as of 4/17/2025, PJT Partners Q1 2024 Secondary Market Insight, April 2024, and PJT Partners Q1 2025 Secondary Market Insight, April 2025.
IMPORTANT INFORMATION
Past performance is not a guide to future results and is not indicative of expected realized returns.
Copyright© Abbott Capital Management, LLC 2025. All rights reserved. This material is proprietary and may not be reproduced or distributed without Abbott’s prior written permission. It is delivered on an “as is” basis without warranty or liability. Abbott accepts no responsibility for any errors, mistakes or omissions or for any action taken in reliance thereon. All charts, graphs and other elements contained within are also copyrighted works and may be owned by Abbott or a party other than Abbott. By accepting the information, you agree to abide by all applicable copyright and other laws, as well as any additional copyright notices or restrictions contained in the information.
The views and information provided are as of May 2025 unless otherwise indicated and are subject to frequent change, update, revision, verification and amendment, materially or otherwise, without notice, as market or other conditions change. There can be no assurance that terms and trends described herein will continue or that forecasts are accurate. Certain statements contained herein are statements of future expectations or forward-looking statements that are based on Abbott’s views and assumptions as of the date hereof and involve known and unknown risks and uncertainties (including those discussed below and in Abbott’s Form ADV Part 2A, available on the SEC’s website at www.adviserinfo.sec.gov) that could cause actual results, performance or events to differ materially and adversely from what has been expressed or implied in such statements. Forward-looking statements may be identified by context or words such as “may, will, should, expects, plans, intends, anticipates, believes, estimates, predicts, potential or continue” and other similar expressions. Neither Abbott, its affiliates, nor any of Abbott’s or its affiliates’ respective advisers, members, directors, officers, partners, agents, representatives or employees or any other person is under any obligation to update or keep current the information contained in this document.
This material is for informational purposes only and is not an offer or a solicitation to subscribe to any fund and does not constitute investment, legal, regulatory, business, tax, financial, accounting or other advice or a recommendation regarding any securities of Abbott, of any fund or vehicle managed by Abbott, or of any other issuer of securities. No representation or warranty, express or implied, is given as to the accuracy, fairness, correctness or completeness of third party sourced data or opinions contained herein and no liability (in negligence or otherwise) is accepted by Abbott for any loss howsoever arising, directly or indirectly, from any use of this document or its contents, or otherwise arising in connection with the provision of such third-party data.
Abbott is pleased to announce that Moritz Turck has been promoted to Managing Director.
Abbott was recognized in the 2025 Best Places to Work in Money Management awards announced by Pensions & Investments.
We are pleased to share our Q3 2025 Private Equity Market Overview.